BioLineRx Ltd.
Hedge Funds Holdings
Last updated:
BioLineRx Ltd.‘s stocks are currently a part of 10 hedge funds’ portfolios, which represents 0.07% of the total amount of its stocks outstanding. This makes up a total of 511.62K shares of BioLineRx Ltd.. Compared to the previous quarter, the number fell by -91.05% or -5.20M shares fewer. As for the holding position changes, 10% (1) of current hedge fund investors increased the number of shares held, 20% (2) of current holders sold a part of the shares held, and 10% (1) closed the holdings completely. 1 hedge funds are new holders of BioLineRx Ltd. stock in Q1 2023, it is 10% of total holders.
Hedge funds holding BioLineRx Ltd. (Q2 2018 – Q1 2023)
| Q2 2018 | 24 |
|---|---|
| Q3 2018 | 26 |
| Q4 2018 | 31 |
| Q1 2019 | 31 |
| Q2 2019 | 24 |
| Q3 2019 | 13 |
| Q4 2019 | 9 |
| Q1 2020 | 9 |
| Q2 2020 | 13 |
| Q3 2020 | 15 |
| Q4 2020 | 18 |
| Q1 2021 | 27 |
| Q2 2021 | 27 |
| Q3 2021 | 28 |
| Q4 2021 | 29 |
| Q1 2022 | 25 |
| Q2 2022 | 27 |
| Q3 2022 | 26 |
| Q4 2022 | 17 |
| Q1 2023 | 10 |
Hedge funds changes in BioLineRx Ltd. positions (Q2 2018 – Q1 2023)
| Q2 2018 | 7 | 3 | 3 | 10 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 8 | 2 | 5 | 6 | 5 |
| Q4 2018 | 8 | 5 | 7 | 3 | 8 |
| Q1 2019 | 6 | 4 | 8 | 5 | 8 |
| Q2 2019 | 2 | 4 | 1 | 8 | 9 |
| Q3 2019 | 12 | 0 | 0 | 22 | -21 |
| Q4 2019 | 2 | 2 | 1 | 6 | -2 |
| Q1 2020 | 2 | 2 | 2 | 2 | 1 |
| Q2 2020 | 7 | 3 | 2 | 3 | -2 |
| Q3 2020 | 4 | 4 | 3 | 2 | 2 |
| Q4 2020 | 8 | 3 | 4 | 5 | -2 |
| Q1 2021 | 12 | 8 | 2 | 3 | 2 |
| Q2 2021 | 6 | 2 | 8 | 6 | 5 |
| Q3 2021 | 6 | 6 | 5 | 5 | 6 |
| Q4 2021 | 6 | 9 | 4 | 5 | 5 |
| Q1 2022 | 5 | 5 | 6 | 6 | 3 |
| Q2 2022 | 6 | 3 | 7 | 5 | 6 |
| Q3 2022 | 7 | 6 | 5 | 8 | 0 |
| Q4 2022 | 3 | 3 | 7 | 11 | -7 |
| Q1 2023 | 1 | 1 | 2 | 1 | 5 |
Hedge funds changes in BioLineRx Ltd. stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 86,000 | 92,000 |
| Q3 2021 | 13,000 | 408,000 |
| Q4 2021 | 54,000 | 101,000 |
| Q1 2022 | 37,000 | 29,000 |
| Q2 2022 | 49,000 | 0 |
| Q3 2022 | 22,000 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |